首页|期刊导航|药物分析学报(英文)|Targeted nano-drug delivery systems for tumor immunotherapy

Targeted nano-drug delivery systems for tumor immunotherapyOA

Targeted nano-drug delivery systems for tumor immunotherapy

Shan Lian;Wenyong Yang;Yan Zeng;Ranran Tang;Kui Wang

West China School of Basic Medical Sciences & Forensic Medicine,State Key Laboratory of Biotherapy,West China Hospital,Sichuan University,Chengdu,610041,ChinaDepartment of Neurosurgery,Medical Research Center,The Affiliated Hospital of Southwest Jiaotong University,The Second Chengdu Hospital Affiliated to Chongqing Medical University,The Third People's Hospital of Chengdu,Chengdu,610041,China||Department of Oncology,The First Affiliated Hospital of Xinxiang Medical University,Weihui,Henan,453199,ChinaWest China School of Basic Medical Sciences & Forensic Medicine,State Key Laboratory of Biotherapy,West China Hospital,Sichuan University,Chengdu,610041,ChinaNanjing Women and Children's Healthcare Institute,Women's Hospital of Nanjing Medical University(Nanjing Women and Children's Healthcare Hospital),Nanjing,210004,ChinaWest China School of Basic Medical Sciences & Forensic Medicine,State Key Laboratory of Biotherapy,West China Hospital,Sichuan University,Chengdu,610041,China

ImmunotherapyTargeted nano-drug delivery systemsTumor microenvironmentImmunogenic cell deathInnate immunityAdaptive immunity

ImmunotherapyTargeted nano-drug delivery systemsTumor microenvironmentImmunogenic cell deathInnate immunityAdaptive immunity

《药物分析学报(英文)》 2026 (1)

35-53,19

This work was supported by the National Natural Science Foundation of China(Grant Nos.:82472734(K.W.),82273122(K.W.),and 82303238(W.Y.)),the Natural Science Foundation of Sichuan Province(Grant No.:2025NSFJQ0059(K.W.)),Science and Technology Support Program of Sichuan Province(Grant No.:2024NSFSC1945(W.Y.)),the Third People's Hospital of Chengdu Clinical Research Program(Program Nos.:CSY-YN-01-2023-013(W.Y.)and CSY-YN-03-2024-003(W.Y.)),Health Commission of Chengdu Medical Research(Program No.:2024291(W.Y.)),and the Nanjing Municipal Health Technology Development Special Fund(Grant No.:YKK24147(R.T.)).

10.1016/j.jpha.2025.101408

评论